LICENSE AGREEMENTAnd License Agreement • March 15th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 15th, 2018 Company Industry JurisdictionTHIS DEVELOPMENT, COMMERCIALIZATION, COLLABORATION, AND LICENSE AGREEMENT is made and entered into as of March 14, 2018 (the “Execution Date”), by and between Akcea Therapeutics, Inc., a Delaware corporation (“Akcea”), and Ionis Pharmaceuticals, Inc., a Delaware corporation (“Ionis”). Akcea and Ionis each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
AKCEA THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 14, 2018Investor Rights Agreement • March 15th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2018 Company IndustryTHIS INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of March 14, 2018 between Akcea Therapeutics Inc., a Delaware corporation (“Akcea” or the “Company”), and Ionis Pharmaceuticals, Inc., a Delaware corporation (“Ionis” or “Investor”).